DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Revex (Nalmefene Hydrochloride) - Published Studies

 
 



Revex Related Published Studies

Well-designed clinical trials related to Revex (Nalmefene)

Nalmefene: a review of its use in the treatment of alcohol dependence. [2013]

A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis. [2011.08]

A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis. [2011]

Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. [2010]

Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers. [2008.07]

Effects of Opioid Receptor Gene Variation on Targeted Nalmefene Treatment in Heavy Drinkers. [2008.06.03]

Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study. [2007.07]

Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. [2006.02]

Well-designed clinical trials possibly related to Revex (Nalmefene)

The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study. [2009.03.31]

Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. [2008.11]

Other research related to Revex (Nalmefene)

Effect of nalmefene 20 and 80 mg on the corrected QT interval and T-wave morphology: a randomized, double-blind, parallel-group, placebo- and moxifloxacin-controlled, single-centre study. [2011.11.01]

Effect of Nalmefene 20 and 80 mg on the Corrected QT Interval and T-Wave Morphology: A Randomized, Double-Blind, Parallel-Group, Placebo- and Moxifloxacin-Controlled, Single-Centre Study. [2011.09.23]

Nalmefene for treatment of alcohol dependence. [2010.11]

Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. [2010.10]

[Clinical observation of the effect of nalmefene in treatment of septic shock] [2010.06]

In vivo characterization of the opioid antagonist nalmefene in mice. [2010.04.10]

[Clinical observation of the effect of nalmefene in treatment of septic shock]. [Article in Chinese] [2010]

[Pharmacokinetics of nalmefene after a single or multiple intravenous doses in Chinese healthy volunteers.] [2008.10]

Targeted Nalmefene With Simple Medical Management in the Treatment of Heavy Drinkers: A Randomized Double-Blind Placebo-Controlled Multicenter Study. [2007.04.19]

Prolonged central mu-opioid receptor occupancy after single and repeated nalmefene dosing. [2005.12]

Determination of nalmefene by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. [2005.04]

Stimulation of the hypothalamic-pituitary-adrenal axis with the opioid antagonist nalmefene. [2005]

Other possibly related research studies

Opioid antagonists for alcohol dependence. [2005.01.25]

Plasma met-enkephalin, beta-endorphin and leu-enkephalin levels in human hepatic encephalopathy. [2007.03]

Emerging pharmacologic options for treating postoperative ileus. [2007.10.15]

Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. [2008.02]

Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review. [2008.11]

Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. [2010.01.20]

Opioid-like compound exerts anti-fibrotic activity via decreased hepatic stellate cell activation and inflammation. [2011.04.15]

Opioid antagonists for alcohol dependence. [2010.12.08]

Human exposures to immobilising agents: results of an online survey. [2010.08.28]

Emerging drugs to treat alcoholism. [2010.12]

Antipruritic treatment with systemic mu-opioid receptor antagonists: a review. [2010.10]

Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. [2010]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017